Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates

Core Viewpoint - Globus Medical reported quarterly earnings of $0.68 per share, missing the Zacks Consensus Estimate of $0.74 per share, and showing a decline from $0.72 per share a year ago, indicating an earnings surprise of -8.11% [1][2] Financial Performance - The company posted revenues of $598.12 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 4.81%, and down from $606.67 million year-over-year [2] - Over the last four quarters, Globus Medical has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - Globus Medical shares have declined approximately 13.5% since the beginning of the year, compared to a decline of -4.3% for the S&P 500 [3] - The current Zacks Rank for Globus Medical is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.86 on revenues of $671.54 million, and for the current fiscal year, it is $3.45 on revenues of $2.68 billion [7] - The estimate revisions trend for Globus Medical is mixed, and future changes in estimates will be closely monitored following the recent earnings report [6][7] Industry Context - The Medical - Instruments industry, to which Globus Medical belongs, is currently ranked in the top 28% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]